Kura Oncology KURA Other Non-Current Liabilities
Other Non-Current Liabilities at other companies
Segments
By product
Other financials
Where this comes from
Reported directly by Kura Oncology in its filing.
Tagged under the XBRL concept us-gaap:OtherLiabilitiesNoncurrent.
The official record: Kura Oncology’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Kura Oncology's other non-current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Kura Oncology's other non-current liabilities?
- Kura Oncology (KURA) reported other non-current liabilities of $3.44M in Q1 2026.
- How has Kura Oncology's other non-current liabilities changed year-over-year?
- Kura Oncology's other non-current liabilities increased by 60.7% year-over-year, from $2.14M to $3.44M.
- What is the long-term trend for Kura Oncology's other non-current liabilities?
- Over 5 years (2020 to 2025), Kura Oncology's other non-current liabilities has grown at a 51.6% compound annual growth rate (CAGR), from $395K to $3.17M.
- What does other non-current liabilities mean?
- Miscellaneous long-term obligations not classified in specific categories — pension liabilities, environmental remediation, and other long-term accruals.